Medicines Australia acknowledges Senator Kim Carr’s contribution to industry and innovation
29 March 2022: Medicines Australia congratulates Senator the Hon Kim Carr on his almost 30 years of service to the Australian Parliament – especially his contributions to industry and innovation – and wishes him well for his future endeavours.
Senator Carr has announced he is not seeking re-election as a Senator for Victoria at the upcoming election.
Medicines Australia CEO, Elizabeth de Somer, said the biopharmaceutical industry benefited from Senator Carr’s strong interest and commitment to science, innovation, higher education, and research – all key drivers of Australia’s health and medicines sectors.
“Senator Carr was first elected in 1993 and served in numerous Ministerial and Shadow Ministerial roles, most notably as Minister for Innovation, Industry, Science, and Research in the Rudd and Gillard Governments,” Ms de Somer said.
“Senator Carr was known as a strong advocate for industry and science throughout his parliamentary career and was always consultative in his dealings with professional associations and other stakeholders.
“He will be especially remembered in the medicines sector for his stewardship of the R&D tax credit legislation, establishing the Pharmaceuticals Industry Strategy Group, and advocating the importance of patent protection.
“Senator Carr made a significant contribution for nearly three decades in Federal politics and leaves an enduring legacy of passion for industry, science and innovation,” Ms de Somer said.
For further information or media interviews, please contact:
Chrystianna Moran – 0424 995 118 / firstname.lastname@example.org.
John Flannery – 0419 494 761 / email@example.com